AA vs REGN · P/E 8.1, rev $12.83B vs P/E 14, rev $14.34B
Alcoa Corp (AA) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Alcoa Corp (AA) is a aluminum company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported AA revenue for 2025-12-31 was $12.83B. Net income was $1.16B. Revenue was up 7.9% from 2024-12-31 to 2025-12-31. AA currently screens at market cap $7.82B and trailing P/E 8.1.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
AA currently screens at market cap $7.82B and trailing P/E 8.1. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the AA and REGN stock pages for the full models.
Not investment advice.